Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma

Rita De Sanctis,1 Andrea Marrari,1 Silvia Marchetti,1 Chiara Mussi,2 Luca Balzarini,3 Fabio Romano Lutman,3 Primo Daolio,4 Stefano Bastoni,4 Alexia Francesca Bertuzzi,1,5 Vittorio Quagliuolo,2 Armando Santoro1 1Department of Medical Oncology and Haematology, 2Department of Surgical Oncology, 3Depar...

Full description

Bibliographic Details
Main Authors:	De Sanctis R, Marrari A, Marchetti S, Mussi C, Balzarini L, Lutman FR, Daolio P, Bastoni S, Bertuzzi AF, Quagliuolo V, Santoro A
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-10-01
Series:	Drug Design, Development and Therapy
Online Access:	https://www.dovepress.com/efficacy-of-trabectedin-in-advanced-soft-tissue-sarcoma-beyond-lipo--a-peer-reviewed-article-DDDT

Similar Items

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma [Corrigendum]
by: De Sanctis R, et al.
Published: (2016-01-01)

Trabectedin in Soft Tissue Sarcomas
by: Bradley J. Petek, et al.
Published: (2015-02-01)

The value of trabectedin in the treatment of soft tissue sarcoma
by: Nakamura T, et al.
Published: (2016-01-01)

Role of trabectedin in the treatment of soft tissue sarcoma
by: Alexandre Christinat, et al.
Published: (2009-05-01)

Trabectedin for advanced soft tissue sarcomas: optimizing use
by: Reid A, et al.
Published: (2014-12-01)

Trabectedin and its potential in the treatment of soft tissue sarcoma
by: Philippe A Cassier, et al.
Published: (2008-03-01)

Trabectedin for the treatment of advanced metastatic soft tissue sarcoma
by: EL Simpson, et al.
Published: (2010-05-01)

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
by: Audrey Laroche, et al.
Published: (2017-04-01)

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
by: Recine F, et al.
Published: (2017-02-01)

Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin
by: Frédéric Amant, et al.
Published: (2015-01-01)

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
by: Desar IME, et al.
Published: (2016-08-01)

Trabectedin for Metastatic Soft Tissue Sarcoma: A Retrospective Single Center Analysis
by: Anthony D. Ho, et al.
Published: (2010-10-01)

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma
by: Maud Maillard, et al.
Published: (2020-12-01)

The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin
by: Gerlinde Egerer, et al.
Published: (2009-07-01)

Trabectedin: Safety and Efficacy in the Treatment of Advanced Sarcoma
by: Csaba Gajdos, et al.
Published: (2011-01-01)

Optimizing Trabectedin Therapy for the Treatment of Ewing Sarcoma
by: Harlow, Matthew
Published: (2017)

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group
by: Emanuela Palmerini, et al.
Published: (2021-03-01)

Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center
by: Nadia Hindi, et al.
Published: (2020-12-01)

Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature Review
by: Francesco Pierantoni, et al.
Published: (2019-07-01)

Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients
by: Michiel C. Verboom, et al.
Published: (2019-01-01)

Case Report of Suspected Rhabdomyolysis during Treatment with Trabectedin in a Patient with Metastatic Leiomyosarcoma
by: W. Lamm, et al.
Published: (2010-12-01)

796 A phase I/II trial combining avelumab and trabectedin for advanced liposarcoma and leiomyosarcoma
by: Michael Wagner, et al.
Published: (2020-11-01)

Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report
by: Viktoria-Anna Nteli, et al.
Published: (2018-02-01)

Long-Term Response after 94 Cycles of Trabectedin in a Patient with Metastatic Leiomyosarcoma of the Lower Extremity
by: Magda Cordeiro, et al.
Published: (2020-02-01)

Long-Term Progression-Free Survival in a Patient with Metastatic Leiomyosarcoma of the Inguinal Region Treated with Trabectedin
by: Ferdinand Haslbauer
Published: (2018-04-01)

Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin
by: Gianmaria Miolo, et al.
Published: (2020-07-01)

Combination of Trabectedin and Gemcitabine for Advanced Soft Tissue Sarcomas: Results of a Phase I Dose Escalating Trial of the German Interdisciplinary Sarcoma Group (GISG)
by: Bernd Kasper, et al.
Published: (2015-01-01)

Trabectedin in Advanced Sarcomas—Experience at a Tertiary Care Center and Review of Literature
by: Saurav Verma, et al.
Published: (2021-04-01)

Canonical Wnt/β-catenin signaling activation in soft-tissue sarcomas: A comparative study of synovial sarcoma and leiomyosarcoma
by: Laurence M Briski, et al.
Published: (2018-11-01)

Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin
by: Alexandre de Nonneville, et al.
Published: (2019-03-01)

Neoadjuvant Trabectedin plus Radiotherapy in High-Grade Sarcoma of the Leg: A Case Report
by: António José Loureiro da Silva, et al.
Published: (2018-07-01)

Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models
by: Lucia Martinez-Cruzado, et al.
Published: (2017-06-01)

Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)
by: María Jesús Rubio, et al.
Published: (2020-08-01)

Cost Effectiveness of First-Line Treatment with Doxorubicin/Ifosfamide Compared to Trabectedin Monotherapy in the Management of Advanced Soft Tissue Sarcoma in Italy, Spain, and Sweden
by: Julian F. Guest, et al.
Published: (2013-01-01)

Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity
by: J. Herzog, et al.
Published: (2016-01-01)

Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer
by: Robin L. Jones, et al.
Published: (2021-06-01)

Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials
by: Makoto Endo, et al.
Published: (2020-06-01)

Trabectedin in Advanced High-Grade Uterine Leiomyosarcoma: A Case Report Illustrating the Value of18FDG-PET-CT in Assessing Treatment Response
by: M.J. Payne, et al.
Published: (2014-02-01)

Phyllodes tumor of the breast whose sarcoma element is leiomyosarcoma
by: Tadashi Terada, M.D., Ph.D.
Published: (2016-03-01)

Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature Review
by: Markus K. Schuler, et al.
Published: (2013-01-01)